Clinical Trial Update: A New Application of Amiloride in the Treatment of Patient With Chronic Kidney Disease In Reducing Urinary PROtein [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating amiloride for reducing urinary protein in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Amiloride (amiloride)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Chronic Kidney Diseases | Phase 4 | Status: COMPLETED